Lv11
42 积分 2023-03-27 加入
Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia
2天前
已完结
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
2天前
已完结
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis
2天前
求助中
Contemporary Management of Acute Myeloid Leukemia
2天前
已完结
New drugs creating new challenges in acute myeloid leukemia
2天前
已完结
Azacitidine and its role in the upfront treatment of acute myeloid leukemia
2天前
已完结
Foreign bodies in the aerodigestive tract in pediatric patients
2天前
已完结
Prognostic significance of HLA-B leader matching status and its relationship with NK cell reconstitution in patients with hematological malignancies following haploidentical transplantation
21天前
已完结
Venetoclax plus a hypomethylating agent versus cytarabine, aclarubicin, and granulocyte colony-stimulating factor chemotherapy as a first-line therapy for newly diagnosed acute myeloid leukemia: A propensity score-matched analysis
21天前
已完结
Molecular and immunophenotypic profiling of leukemia cutis in acute myeloid leukemia: A retrospective matched-cohort study
21天前
已完结
皖公网安备34019202002308
